Drugs News and Research

RSS

Tablet containing cannabidiol effectively reduces pain after shoulder surgery

An orally absorbed tablet containing cannabidiol (CBD) effectively reduces pain after shoulder surgery with no safety concerns, a new study finds.

25 Mar 2022

Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction

A new study has focussed on screening and identification of possible SMIs of this PPI for COVID-19.

25 Mar 2022

Algae found to inhibit SARS-CoV-2 infection in vitro

A new study demonstrated that dry algal powders inhibit SARS-CoV-2 in vitro.

25 Mar 2022

Understanding a New Mutation in Pediatric AML

News-Medical speaks to Dr. Jeffery Klco about acute myeloid leukemia (AML) and his recent research that is helping us to understand a new mutation in pediatric AML.

25 Mar 2022

Reduced kidney function caused by antithrombotic therapy can influence bleeding events

Antithrombotic therapy is prescribed to prevent thrombotic (blood clotting inside a blood vessel) events but the treatment also increases the likelihood of experiencing a bleeding event, which can be extremely serious if it occurs in a vital organ.

25 Mar 2022

Prolonged bed rest immediately after embryo transfer linked with reduction in chances of pregnancy

Many clinical interventions used during in-vitro fertilization (IVF), including ultrasound guidance at the time of embryo transfers appear to increase pregnancy rates, however prolonged bed rest should not be recommended, finds a new study led by UCL researchers.

25 Mar 2022

Shorter course of antibiotics associated with fewer antibiotic resistance genes

Antibiotic resistance is a growing problem worldwide that threatens the efficacy of available treatments and can lead to extended hospital stays and increased mortality.

24 Mar 2022

Older people taking statins have lower chance of developing parkinsonism later, study suggests

Parkinsonism is a term for a group of neurological conditions that cause movement problems including tremors, slowed movement and stiffness, with Parkinson's disease being one of the better knowns causes.

24 Mar 2022

Short duration treatment effective in combating most childhood TB cases, study says

Short duration treatment — four months instead of the standard six — is as effective in combating most cases of childhood tuberculosis (TB), says a study carried out in India and some African countries.

24 Mar 2022

Antidopaminergic antiemetics associated with elevated risk of ischemic stroke

Drugs known as antidopaminergic antiemetics (ADAs) that are widely used to relieve nausea and vomiting caused, for instance, by migraine, chemotherapy or radiotherapy, and after surgery are associated with an increased risk of ischaemic stroke, finds a study published by The BMJ today.

24 Mar 2022

Discovery could help explain why certain infections are hard to get rid of

A new study led by researchers at University of Utah Health details a novel mechanism that infectious bacteria use to quickly adjust to environmental stress. The discovery could help explain why certain types of common infections - such as urinary tract and bloodstream infections like sepsis- are hard to get rid of.

24 Mar 2022

World Tuberculosis Day 2022: an interview with Dr. Maxine Caws

For World Tuberculosis Day 2022, News Medical spoke to Dr. Maxine Caws to raise awareness of this infectious disease.

24 Mar 2022

World Tuberculosis Day 2022: an interview with Dr. Michael Lauzardo

For World Tuberculosis Day 2022, News Medical spoke to Dr. Michael Lauzardo, director of the Southeastern National TB Center, to raise awareness of this infectious disease.

24 Mar 2022

Deep-water cone snails produce a potentially painkilling compound, study reports

Scientists already know that the venom of cone snails, which prowl the ocean floor for a fish dinner, contains compounds that can be adapted as pharmaceuticals to treat chronic pain, diabetes and other human maladies.

24 Mar 2022

Study uncovers a gene that strongly associates with breast cancer patient's treatment outcomes

A multidisciplinary team of researchers from Roswell Park Comprehensive Cancer Center and Kaiser Permanente Northern California have identified the first pharmacogenomic marker for anthracyclines and HER2-targeting drugs, two commonly used breast cancer chemotherapies.

23 Mar 2022

Niacin limits Alzheimer's disease progression in animal model

Indiana University School of Medicine researchers found that niacin limits Alzheimer's disease progression when used in models in the lab, a discovery that could potentially pave the way toward therapeutic approaches to the disease.

23 Mar 2022

New therapy makes immunologically 'cold' tumors hot enough for immune attack

Pancreatic cancer is notoriously difficult to cure or even treat. Now, a new strategy devised by scientists at Albert Einstein College of Medicine has succeeded in making pancreatic tumors visible to the immune systems of mice and vulnerable to immune attack, reducing cancer metastases by 87%.

23 Mar 2022

Scientists develop first drug to treat uncontrolled secretion of mucins in the airways

A multicenter research team co-led by The University of Texas MD Anderson Cancer Center developed the first drug to treat the uncontrolled secretion of mucins in the airways, which causes potentially life-threatening symptoms in millions of Americans with asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF), as well as lung disease resulting from cancer and cancer treatment.

23 Mar 2022

Biomarker testing in lung cancer patients has increased in real-world clinical practice, study reveals

More than half of patients diagnosed with advanced non-small cell lung cancer (NSCLC) undergo biomarker testing, and this figure has increased over the last five years, reveal real-world data from a Spanish national registry study reported at the European Lung Cancer Congress, 30 March-2 April 2022.

23 Mar 2022

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

Just one dose of a new nanoparticle-based COVID-19 vaccine was enough to produce an immune response in animals on track with vaccines currently in clinical use.

23 Mar 2022

Drugs News and Research

Tablet containing cannabidiol effectively reduces pain after shoulder surgery

Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction

Algae found to inhibit SARS-CoV-2 infection in vitro

Understanding a New Mutation in Pediatric AML

Reduced kidney function caused by antithrombotic therapy can influence bleeding events

Prolonged bed rest immediately after embryo transfer linked with reduction in chances of pregnancy

Shorter course of antibiotics associated with fewer antibiotic resistance genes

Older people taking statins have lower chance of developing parkinsonism later, study suggests

Short duration treatment effective in combating most childhood TB cases, study says

Antidopaminergic antiemetics associated with elevated risk of ischemic stroke

Discovery could help explain why certain infections are hard to get rid of

World Tuberculosis Day 2022: an interview with Dr. Maxine Caws

World Tuberculosis Day 2022: an interview with Dr. Michael Lauzardo

Deep-water cone snails produce a potentially painkilling compound, study reports

Study uncovers a gene that strongly associates with breast cancer patient's treatment outcomes

Niacin limits Alzheimer's disease progression in animal model

New therapy makes immunologically 'cold' tumors hot enough for immune attack

Scientists develop first drug to treat uncontrolled secretion of mucins in the airways

Biomarker testing in lung cancer patients has increased in real-world clinical practice, study reveals

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News